The Health Care Select Sector SPDR® Fund Newsroom

Sector Update: Health Care Stocks Lean Lower Premarket Tuesday

MT Newswires21minutes ago

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Amid Fears of Russian Escalation

MT Newswires08:25 ET

Leading And Lagging Sectors For November 19, 2024

Benzinga08:10 ET

Merck Says Injectable Keytruda Succeeded in Late-stage Trial

Seeking Alpha07:14 ET

AbbVie Snaps Eight Straight Sessions of Losses

Seeking Alpha17:51 ET

Johnson & Johnson Announced Topline Results From ICONIC-LEAD, A Pivotal Phase 3 Investigational Study Of Icotrokinra, The First Targeted Oral Peptide That Selectively Blocks The IL-23 Receptor, In Adults And Adolescents 12 Years Of Age And Older With...

Benzinga16:32 ET

Monday Market Slow but Steady, Trump Buying Crypto Firm | Wall Street Today

Kevin Travers16:21 ET

US Stocks Rebound, Tesla Rallies, Bitcoin Soars Above $92,000: What's Driving Markets Monday?

Benzinga13:14 ET

Weekly ETF Flows: SPY Records Inflows, Bitcoin Funds See Large Influx of Capital

Seeking Alpha12:10 ET

Monday Opens to S&P 500 Climb, Dow Slides as Eyes Look Toward Nvidia | Live Stock

Kevin Travers11:21 ET

Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure

BenzingaNov 18 10:04 ET

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Monday as Investors Refocus on Earnings

MT NewswiresNov 18 08:35 ET

Eli Lilly's Tirzepatide Cuts Risk of Worsening Heart Failure in HFpEF, Obese Patients

Seeking AlphaNov 18 06:45 ET

Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone

BenzingaNov 18 03:07 ET

Hedge Funds Were Net Buyers of Financials, Healthcare for Week: Goldman Sachs

Seeking AlphaNov 17 16:05 ET

This Momentum Indicator Says the S&P Won't Peak Until Next Year

Seeking AlphaNov 17 12:11 ET

Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers

BenzingaNov 17 09:20 ET

Goldman Sachs Economist: Weight-Loss Drugs Could Be Key To US Economic Growth

BenzingaNov 17 08:00 ET

The "Diet Duo" leads a sharp decline in pharmaceutical stocks, as Trump's new health secretary opposes vaccines and weight loss drugs.

Kennedy, known as the "anti-vaccine pioneer," strongly opposes GLP-1 drugs, believing they are the wrong approach to addressing the obesity crisis. On Friday, the stock prices of the "weight loss giants" eli lilly and co and novo-nordisk a/s fell by 4.93% and 3.4%, respectively, and other companies dedicated to developing weight loss drugs also suffered heavy losses.

wallstreetcnNov 17 07:00 ET

First Mpox Case Linked to African Outbreak Reported in U.S.

Seeking AlphaNov 17 01:50 ET